Showing results (411-420 of 2,888) with videos related to
Sort By:
Pageof 289
Stroke|February 19, 2017
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-AnalysisYing Bai, Hai Deng, Alena Shantsila, et al.Thrombosis Research|March 18, 2017
Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative studyDanielle E Clarkesmith, Gregory Y H Lip, Deirdre A LaneInternational Journal of Cardiology|May 15, 2015
Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomesQinmei Xiong, Marco Proietti, Keitaro Senoo, et al.Journal of Human Hypertension|August 5, 2020
Hypertension management in cardio-oncologyHani Essa, Rebecca Dobson, David Wright, et al.Discovery Medicine|June 30, 2012
Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugsIngo Ahrens, Karlheinz Peter, Gregory Y H Lip, et al.Journal of Thrombosis and Thrombolysis|April 5, 2025
The use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of long-COVID/post-acute sequelae of SARS-CoV-2 infectionFreddy Frost, José Miguel Rivera-Caravaca, Gregory Y H LipJournal of Clinical Medicine|April 27, 2024
Comparing the Real-World and Clinical Trial Bleeding Rates Associated with Oral Anticoagulation Treatment for Atrial FibrillationYing Gue, Dan Bloomfield, Debra Freedholm, et al.Journal of the American College of Cardiology|June 9, 2022
Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art ReviewAmir Ajoolabady, Stanley Nattel, Gregory Y H Lip, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2008
Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' ruleHoong Sern Lim, Gregory Y H Lip, Hung-Fat TseJournal of Arrhythmia|March 17, 2025
Renal function decline in Asian patients with atrial fibrillation with warfarin and non-vitamin K antagonist oral anticoagulants: A report from the COOL-AF registryRungroj Krittayaphong, Sukrit Treewaree, Ahthit Yindeengam, et al.Pageof 289